Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merger with Ignite Proteomics.
Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merger with Ignite Proteomics.